#SFHS2531886AOrder Setting Fixed Amounts for Medical Telemonitoring Activities
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law establishes fixed reimbursement amounts for medical telemonitoring activities, particularly for various diabetes types, chronic kidney failure, chronic heart failure, and cancer monitoring. The order specifies payment amounts per patient for each type of telemonitoring service, ensuring that medical providers receive consistent and predetermined compensation for their services in remote patient management.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Introduces specific reimbursement amounts for telemonitoring activities
- Specifies different amounts based on medical conditions
- Clarifies the implementation timeline for the order
Obligations
What this law requires
Medical device distributors and operators must ensure reimbursement for Type 1 and Type 2 diabetes telemonitoring services at a fixed monthly rate of €48.46 per patient
Medical device distributors and operators must ensure reimbursement for gestational diabetes telemonitoring services at a fixed monthly rate of €49.79 per patient across approved platforms (GLOOKO XT, MY DIABBY)
Medical device distributors and operators must ensure reimbursement for chronic kidney failure dialysis/transplant telemonitoring services at a fixed monthly rate of €45.56 per patient
Medical device distributors and operators must ensure reimbursement for chronic heart failure telemonitoring services at fixed monthly rates of €39.94 to €73.87 per patient depending on the platform
Medical device distributors and operators must ensure reimbursement for localized cancer telemonitoring services at a fixed monthly rate of €44.73 per patient